| OncLive | Frontline Pembrolizumab Explored in Head and Neck Cancer OncLive The ongoing phase III KEYNOTE-412 trial is evaluating the efficacy of pembrolizumab (Keytruda) in combination with chemoradiation (CRT) versus CRT alone as frontline therapy in patients with newly diagnosed locally advanced head and neck squamous ... |
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vWSyy6
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,